MoneyWorks4Me

Biocon - Quaterly Results

27 Jul 2022 Evaluate
The revenue zoomed 15.42% to Rs. 4417.00 millions for the quarter ended June 2022 as compared to Rs. 3827.00 millions during the corresponding quarter last year.The Company to register a -48.80%  fall in the net profit for the quarter ended June 2022.Operating profit for the quarter ended June 2022 decreased to 512.00 millions as compared to 727.00 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4417.00 3827.00 15.42 4417.00 3827.00 15.42 17382.00 20284.00 -14.31
Other Income 486.00 492.00 -1.22 486.00 492.00 -1.22 1872.00 1502.00 24.63
PBIDT 512.00 727.00 -29.57 512.00 727.00 -29.57 2483.00 4627.00 -46.34
Interest 1.00 2.00 -50.00 1.00 2.00 -50.00 4.00 4.00 0.00
PBDT 511.00 725.00 -29.52 511.00 725.00 -29.52 2479.00 4623.00 -46.38
Depreciation 286.00 260.00 10.00 286.00 260.00 10.00 1082.00 1035.00 4.54
PBT 225.00 465.00 -51.61 225.00 465.00 -51.61 1397.00 3588.00 -61.06
TAX 76.00 174.00 -56.32 76.00 174.00 -56.32 536.00 783.00 -31.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 149.00 291.00 -48.80 149.00 291.00 -48.80 861.00 2805.00 -69.30
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6000.00 0.05
PBIDTM(%) 11.59 19.00 -38.98 11.59 19.00 -38.98 14.28 22.81 -37.38
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..